Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xuecheng Pang
Institution:
Cangzhou Central Hospital
Observed institutions:
Cangzhou Central Hospital,
International Federation of Gynaecology and Obstetrics
ORCID:
0000-0002-4023-363X
Observed ORCID:
0000-0002-4023-363X
OpenAlex ID:
A5018129262
Development and validation of m6A regulators’ prognostic significance for endometrial cancer
2021
·
Xuecheng Pang
, Xiang Zhang
, et al.
·
Medicine
·
11
A seven-m6A regulator-related CpG site-based prognostic signature for endometrial carcinoma
2021
·
Xiang Zhang
, Xuecheng Pang
, et al.
·
Medicine
·
8
[WITHDRAWN] miR-144-3p Functions as a Tumor Suppressor in Endometrial Cancer by Targeting PRR11
2022
·
Huihui Song
, Hong Sun
, et al.
·
The American Journal of the Medical Sciences
·
3
Erianin Suppresses Endometrial Cancer Progression by Regulating the miR-661/BOK Axis
2021
·
Xuecheng Pang
, Xiang Zhang
, et al.
·
Revista Brasileira de Farmacognosia
·
3
A stemness-based signature with inspiring indications in discriminating the prognosis, immune response, and somatic mutation of endometrial cancer patients revealed by machine learning
2024
·
Xuecheng Pang
, Yu Wang
, et al.
·
Aging
·
2
PDF
Identification of seven cuproptosis-related lncRNAs signature and establishment of a prognostic nomogram predicting overall survival in patients with endometrial cancer
2022
·
Xuecheng Pang
, Sumin Qian
·
Research Square
·
1
PDF
Value of serum p53, PKD1, and MAP2K4 in evaluating the condition and prognosis of endometrial carcinoma.
2022
·
Xiang Zhang
, Yue Huang
, et al.
·
PubMed
·
1
Mendelian randomization analysis of PKD1 in endometrial cancer and comparative multi-cancer study with renal cell carcinoma
2026
·
Xuecheng Pang
, Yu Wang
, et al.
·
Discover Oncology
Show more works
View as search
Works count:
8
Citation count:
29
H-index:
3
I10-index:
1
Year
Topic
Type
